NEW YORK (GenomeWeb News) — Illumina and its Solexa subsidiary today said that they have filed a countersuit in response to a DNA sequencing patent-infringement lawsuit brought against them last month by Life Technologies and its subsidiary Applied Biosystems.

In their filing, Illumina and Solexa have denied all of Life's and ABI's allegations of patent infringement, and they have asserted that ABI's licensed patents are invalid.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.

Apr
15
Sponsored by
WaferGen

This live online seminar will highlight recent trends in applying next-generation sequencing in the clinical setting, with a particular focus on oncology and rare disease.